ArticleFrontiers in cardiovascular medicine2026
Precision cardiovascular medicine: global imperative for equity through innovation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease remains the world's leading cause of death, with a disproportionate burden falling on low- and middle-income countries. Emerging precision medicine approaches, such as artificial intelligence, multiomics, and digital diagnostics, offer transformational potential for prevention and management. Yet, without equity-centered policies, these innovations risk amplifying disparities. The World Heart Federation (WHF) proposes a framework premised on innovation as a public good and equity as a universal right. Through the World Heart Observatory, Digital Health Roadmap, and Emerging Leaders Program, the WHF operationalizes equity across governance, workforce, and care delivery. Drawing on exemplars from Africa, Latin America, and South/Southeast Asia, we outline implementation strategies and policy levers to translate science into population-level impact. Precision cardiovascular medicine can become the standard for all-but only when designed with equity from inception.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.